The new technical partnership between Inspirata and Flagship Biosciences provides clinicians with a seamless, fully automated AI send-out solution, offering significant advantages over standard material transfers.Tampa, FL and Westminster, CO – (Globe Newswire)...
News
Pharma Tech Outlook Cover Story: Flagship Biosciences – Accelerating Drug Development
As one of the industry’s leading tissue data and image analysis services providers, Flagship Biosciences was recently selected as a Top Image Analysis Solution Provider for 2020. With advanced tissue image analysis solutions that give pharmaceutical and diagnostics...
Accelerating Drug Development as a Top Image Analysis Solution Provider for 2020
As featured in Pharma Tech Outlook Magazine, July 2020Flagship Biosciences was recently selected as a Top Image Analysis Solution Provider for 2020 by Pharma Tech Outlook Magazine. Flagship’s proprietary tissue image analysis solutions provide both pharmaceutical and...
Flagship Spotlight: Brenna O’Neill
Brenna O’Neill, Image Analyst for Flagship Biosciences, received her M.S. Ecology and B.S. Marine Biology at Florida Institute of Technology. Brenna knew from a very young age that she would be some kind of scientist. She recently shared more about the early life...
Flagship Biosciences Launches New Clinical Diagnostics Service
TissueInsight Immuno-Oncology Service Offers Data for Advanced Cancer Patient CareJune 30, 2020 — Flagship Biosciences, providers of expert tissue data insights, today announced the launch of a new clinical diagnostics immuno-oncology service, TissueInsight....
Biomarkers Strategies and Implementation for Drug Development (Regulatory Webcast Summary)
Flagship Biosciences recently hosted a webcast on Biomarkers: Strategies and Implementation, and Drug Development. Introduced by our COO Meredith James, we were pleased to have our colleague Suzana Corritori, MD, PhD, MSc present her thoughts on a strategic approach...
Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.
Recent Posts
PUBLICATIONS
Protein Tyrosine Kinase 7 (PTK7) Biomarker Analysis in Patients treated with PF-06647020, a PTK7 Antibody-Drug Conjugate (ADC), in a Phase I Dose Expansion Study
BACKGROUND F-06647020, an ADC comprising a humanized monoclonal antibody against PTK7, a cleavable valine-citrulline linker, and an auristatin payload, is being investigated in an ongoing Phase I clinical trial in patients with advanced solid tumors. We hypothesized...
Comprehensive Image Analysis Of Immunostained NSCLC Tissues Provides Necessary Context For Immune Oncology Biomarker Profiling
Key Takeaways Manual pathology assessment is challenging and variable, limiting the data interpretation required for meaningful spatial biology analysis Unlike manual assessment, artificial intelligence and machine learning technologies analyze the complex...
Artificial Intelligence Assisted Macrophage Identification in Tumor Biopsies
Key Takeaways Classifying macrophages is important in understanding response to immunotherapy, but it may be challenging to do by eye Using an immunofluorescence-guided machine learning algorithm provided accurate macrophage classification This algorithm is useful in...
EVENTS
American Society of Gene and Cell Therapy Annual Meeting
Visit us at booth 821 at the ASGCT Annual Meeting. We help you analyze more data in more depth, so you can produce more effective therapies. Attending the ASGCT Annual Meeting? Schedule a meeting with our team to discuss our: AI-powered digital pathology solutions...
American Association for Cancer Research Annual Meeting
Visit Us at Booth 2866 in the West Building, Level 2 Flagship Biosciences is your source for spatial biology expertise, moving your research forward every step of the way. Our mission is to explore complex biomarkers within the context of disease in order to advance...
Gene Therapy for Muscular Disorders
Reuniting 100+ leading experts in biotech, pharma, and academia. February 21-23, 2023. We’re headed to Boston to join other leading experts in biotech, pharma and academia to discuss obstacles in clinical trials and strategies for delivering safer and more effective...